Reprogramming the kidney: A novel approach for regeneration

Kidney International

Volumn 82, Issue 2, 2012, Pages 138-146

  Hendry, Caroline E ^a,b   Little, Melissa H ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DIFFERENTIATION; CELL LINEAGE; CHRONIC KIDNEY DISEASE; DNA METHYLATION; DOPAMINERGIC NERVE CELL; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; GATA1 GENE; GENE; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GENOTYPE; HISTONE ACETYLATION; HUMAN; KIDNEY REGENERATION; MEDICAL RESEARCH; MESENCHYMAL STEM CELL; MESENCHYME; NEPHRON; NEUTROPHIL; NONHUMAN; NUCLEAR REPROGRAMMING; ORGANOGENESIS; PANCREAS ISLET BETA CELL; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PU 1 GENE; REVIEW; TISSUE REGENERATION;

EID: 84863333338     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.68     Document Type: Review

References (86)

1. Zhou Q, Brown J, Kanarek A et al. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 2008; 455: 627-632.
2. Gurdon JB, Melton DA. Nuclear reprogramming in cells. Science 2008; 322: 1811-1815.
3. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676.
4. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-872.
5. Stadtfeld M, Hochedlinger K. Induced pluripotency: history, mechanisms, and applications. Genes Dev 2010; 24: 2239-2263.
6. Aasen T, Raya A, Barrero MJ et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 2008; 26: 1276-1284.
7. Loh YH, Agarwal S, Park IH et al. Generation of induced pluripotent stem cells from human blood. Blood 2009; 113: 5476-5479.
8. Sun N, Panetta NJ, Gupta DM et al. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci USA 2009; 106: 15720-15725.
9. Ahmed RP, Haider HK, Buccini S et al. Reprogramming of skeletal myoblasts for induction of pluripotency for tumor-free cardiomyogenesis in the infarcted heart. Circ Res 2011; 109: 60-70.
10. Song B, Niclis JC, Alikhan MA et al. Generation of induced pluripotent stem cells from human kidney mesangial cells. J Am Soc Nephrol 2011; 22: 1213-1220.
11. Zhou T, Benda C, Duzinger S et al. Generation of induced pluripotent stem cells from urine. J Am Soc Nephrol 2011; 22: 1221-1228.
12. Vierbuchen T, Ostermeier A, Pang ZP et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010; 463: 1035-1041.
13. Ieda M, Fu JD, Delgado-Olguin P et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010; 142: 375-386.
14. Dekel B, Zangi L, Shezen E et al. Isolation and characterization of nontubular sca-1+lin-multipotent stem/progenitor cells from adult mouse kidney. J Am Soc Nephrol 2006; 17: 3300-3314.
15. Challen GA, Bertoncello I, Deane JA et al. Kidney side population reveals multilineage potential and renal functional capacity but also cellular heterogeneity. J Am Soc Nephrol 2006; 17: 1896-1912.
16. Hopkins C, Li J, Rae F et al. Stem cell options for kidney disease. J Pathology 2009; 217: 265-281.
17. Appel D, Kershaw DB, Smeets B et al. Recruitment of podocytes from glomerular parietal epithelial cells. J Am Soc Nephrol 2009; 20: 333-343.
18. Ronconi E, Sagrinati C, Angelotti ML et al. Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Nephrol 2009; 20: 322-332.
19. Little MH, Bertram JF. Is there such a thing as a renal stem cell? J Amer Soc Nephrol 2009; 20: 2112-2117.
20. Graf T, Enver T. Forcing cells to change lineages. Nature 2009; 462: 587-594.
21. Visvader JE, Elefanty AG, Strasser A et al. GATA-1 but not SCL induces megakaryocytic differentiation in an early myeloid line. EMBO J 1992; 11: 4557-4564.
22. Kulessa H, Frampton J, Graf T. GATA-1 reprograms avian myelomonocytic cell lines into eosinophils, thromboblasts, and erythroblasts. Genes Dev 1995; 9: 1250-1262.
23. Nerlov C, Graf T. PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev 1998; 12: 2403-2412.
24. Arinbou Y, Mizuno S, Chong Y et al. Reciprocal activation of GATA-1 and PU.1 marks initial specification of hematopoietic stem cells into myeloerythroid and myelolymphoid lineages. Cell Stem Cell 2007; 1: 416-427.
25. Iwasaki H, Akashi K. Hematopoietic developmental pathways: on cellular basis. Oncogene 2007; 26: 6687-6696.
26. Graf T, Busslinger M. B young again. Immunity 2008; 28: 606-608.
27. Waddington C. The Strategy of the Genes. Geo Allen and Unwin: London, 1957.
28. Xie H, Ye M, Feng R et al. Stepwise reprogramming of B cells into macrophages. Cell 2004; 117: 663-676.
29. Macarthur BD, Ma'ayan A, Lemischka IR. Systems biology of stem cell fate and cellular reprogramming. Nat Rev Mol Cell Biol 2009; 10: 672-681.
30. Milnor J. On the concept of attractor. Commun Math Phys 1985; 99: 177-195.
31. Huang S. Reprogramming cell fates: reconciling rarity with robustness. Bioessays 2009; 31: 546-560.
32. Chang HH, Hemberg M, Barahona M et al. Transcriptome-wide noise controls lineage choice in mammalian progenitor cells. Nature 2008; 453: 544-547.
33. Becskei A, Seraphin B, Serrano L. Positive feedback in eukaryotic gene networks: cell differentiation by graded to binary response conversion. EMBO J 2001; 20: 2528-2535.
34. Nakagawa M, Koyanagi M, Tanabe K et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotech 2008; 26: 101-106.
35. Hanna J, Saha K, Pando B et al. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 2009; 462: 595-601.
36. Wernig M, Meissner A, Cassady JP et al. c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2008; 2: 10-12.
37. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007; 448: 313-317.
38. Bussmann LH, Schubert A, Vu Manh TP et al. A robust and highly efficient immune cell reprogramming system. Cell Stem Cell 2009; 5: 554-566.
39. Eminli S, Founda A, Stadtfeld M et al. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat Genet 2009; 41: 968-976.
40. Kim JB, Zaehres H, Wu G et al. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 2008; 454: 646-650.
41. Hajkova P, Erhardt S, Lane N et al. Epigenetic reprogramming in mouse primordial germ cells. Mech Dev 2002; 117: 15-23.
42. Marion RM, Blasco MA. Telomere rejuvenation during nuclear reprogramming. Curr Opin Genet Dev 2010; 20: 190-196.
43. Hochedlinger K, Plath K. Epigenetic reprogramming and induced pluripotency. Development 2009; 136: 509-523.
44. Kim K, Doi A, Wen B et al. Epigenetic memory in induced pluripotent stem cells. Nature 2010; 467: 285-290.
45. Grigoriadis AE, Kennedy M, Bozec A et al. Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells. Blood 2010; 115: 2769-2776.
46. Niwa A, Heike T, Umeda K et al. A novel serum-free monolayer culture for orderly hematopoietic differentiation of human pluripotent cells via mesodermal progenitors. PLoS One 2011; 6: e22261.
47. Kim D, Dressler GR. Nephrogenic factors promote differentiation of mouse embryonic stem cells into renal epithelia. J Am Soc Nephrol 2005; 16: 3527-3534.
48. Lin SA, Kolle G, Grimmond SM et al. Subfractionation of differentiating human embryonic stem cell populations allows the isolation of a mesodermal population enriched for intermediate mesoderm and putative renal progenitors. Stem Cells Dev 2010; 19: 1637-1648.
49. Utikal J, Polo JM, Stadtfeld M et al. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 2009; 460: 1145-1148.
50. Szabo E, Rampalli S, Risueño RM et al. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 2010; 468: 521-526.
51. Kim J, Efe JA, Zhu S et al. Direct reprogramming of mouse fibroblasts to neural progenitors. Proc Natl Acad Sci USA 2011; 108: 7838-7843.
52. Kobayashi A, Valerius MT, Mugford JW et al. Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. Cell Stem Cell 2008; 3: 169-181.
53. Boyle S, Misfeldt A, Chandler KJ et al. Fate mapping using Cited1-CreERT2 mice demonstrates that the cap mesenchyme contains self-renewing progenitor cells and gives rise exclusively to nephronic epithelia. Dev Biol 2008; 313: 234-245.
54. Hartman HA, Lai HL, Patterson LT. Cessation of renal morphogenesis in mice. Dev Biol 2007; 310: 379-387.
55. Rumballe BA, Georgas KM, Combes AN et al. Nephron formation adopts a novel spatial topology at cessation of nephrogenesis. Dev Biol 2011; 360: 110-122.
56. Lusis M, Li J, Ineson J et al. Isolation and culture of metanephric mesenchyme-derived nephrospheres reinforces evidence that embryonic renal progenitors are multipotent and exhaust during cessation of nephron formation. Stem Cell Res 2010; 5: 23-39.
57. Hendry C, Rumballe B, Moritz K et al. Defining and redefining the nephron progenitor population. Pediatr Nephrol 2011; 26: 1395-1406.
58. Nishinakamura R, Matsumoto Y, Nakao K et al. Murine homolog of SALL1 is essential for ureteric bud invasion in kidney development. Development 2001; 128: 3105-3115.
59. Jiang Q, Fujimura S, Kobayashi C et al. Overexpression of Sall1 in vivo leads to reduced body weight without affecting kidney development. J Biochem 2010; 147: 445-450.
60. Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318: 1917-1920.
61. Ichida JK, Blanchard J, Lam K et al. A small-molecule inhibitor of tgf-beta signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell 2009; 5: 491-503.
62. Herzlinger D, Qiao J, Cohen D et al. Induction of kidney epithelial morphogenesis by cells expressing Wnt-1. Dev Biol 1994; 166: 815-818.
63. Sims-Lucas S, Young RJ, Martinez G et al. Redirection of renal mesenchyme to stromal and chondrocytic fates in the presence of TGF-beta2. Differentiation 2010; 79: 272-284.
64. Dudley AT, Godin RE, Robertson EJ. Interaction between FGF and BMP signaling pathways regulates development of metanephric mesenchyme. Genes Dev 1999; 13: 1601-1613.
65. Barasch J, Qiao J, McWilliams G et al. Ureteric bud cells secrete multiple factors, including bFGF, which rescue renal progenitors from apoptosis. Am J Physiol 1997; 273(5 Part 2): F757-F767.
66. Perantoni AO, Timofeeva O, Naillat F et al. Inactivation of FGF8 in early mesoderm reveals an essential role in kidney development. Development 2005; 132: 3859-3871.
67. Jessberger S, Toni N, Clemenson Jr GD et al. Directed differentiation of hippocampal stem/progenitor cells in the adult brain. Nat Neurosci 2008; 11: 888-893.
68. Burton Q, Cole LK, Mulheisen M et al. The role of Pax2 in mouse inner ear development. Dev Biol 2004; 272: 161-175.
69. Zou D, Silvius D, Rodrigo-Blomqvist S et al. Eya1 regulates the growth of otic epithelium and interacts with Pax2 during the development of all sensory areas in the inner ear. Dev Biol 2006; 298: 430-441.
70. Zheng W, Huang L, Wei ZB et al. The role of Six1 in mammalian auditory system development. Development 2003; 130: 3989-4000.
71. Fotaki V, Price DJ, Mason JO. Newly identified patterns of Pax2 expression in the developing mouse forebrain. BMC Dev Biol 2008; 8: 79.
72. Schlosser G, Awtry T, Brugmann SA et al. Eya1 and Six1 promote neurogenesis in the cranial placodes in a SoxB1-dependent fashion. Dev Biol 2008; 320: 199-214.
73. Xu PX, Zheng W, Laclef C et al. Eya1 is required for the morphogenesis of mammalian thymus, parathyroid and thyroid. Development 2002; 129: 3033-3044.
74. Zou D, Silvius D, Davenport J et al. Patterning of the third pharyngeal pouch into thymus/parathyroid by Six and Eya1. Dev Biol 2006; 293: 499-512.
75. Fougerousse F, Durand M, Lopez S et al. Six and Eya expression during human somitogenesis and MyoD gene family activation. J Muscle Res Cell Motil 2002; 23: 255-264.
76. Gupta S, Verfaillie C, Chmielewski D et al. Isolation and characterization of kidney-derived stem cells. J Am Soc Nephrol 2006; 17: 3028-3040.
77. Bussolati B, Bruno S, Grange C et al. Isolation of renal progenitor cells from adult human kidney. Am J Pathol 2005; 166: 545-555.
78. Sagrinati C, Netti GS, Mazzinghi B et al. Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J Am Soc Nephrol 2006; 17: 2443-2456.
79. Unbekandt M, Davies JA. Dissociation of embryonic kidneys followed by reaggregation allows the formation of renal tissues. Kidney Int 2010; 77: 407-416.
80. Diep CQ, Ma D, Deo RC et al. Identification of adult nephron progenitors capable of kidney regeneration in zebrafish. Nature 2011; 470: 95-100.
81. Cohen T, Loutochin O, Amin M et al. PAX2 is reactivated in urinary tract obstruction and partially protects collecting duct cells from programmed cell death. Am J Physiol Renal Physiol 2007; 292: F1267-F1273.
82. Villanueva S, Céspedes C, Vio CP. Ischemic acute renal failure induces the expression of a wide range of nephrogenic proteins. Am J Physiol Regul Integr Comp Physiol 2006; 290: R861-R870.
83. Thiagarajan RD, Georgas KM, Rumballe BA et al. Identification of anchor genes during kidney development defines ontological relationships, molecular subcompartments and regulatory pathways. PLoS One 2011; 6: e17286.
84. Nagy A, Nagy K. The mysteries of induced pluripotency: where will they lead? Nat Methods 2010; 7: 22-24.
85. Efe JA, Hilcove S, Kim J et al. Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nat Cell Biol 2011; 13: 215-222.
86. Benoit G, Machuca E, Heidet L et al. Hereditary kidney diseases: highlighting the importance of classical Mendelian phenotypes. Ann NY Acad Sci 2010; 1214: 83-98.